Search results “#healthcare”
Updated: Oct 16, 2014 In 2013, Ranbaxy had paid around $4,20,000 to the U.S. state of Idaho as part of a $500-million settlement that the drug firm had signed with U.S. authorities. File photo: P.V. Sivakumar Ranbaxy Laboratories, which has… Continue Reading →
In April 2014, the World Health Organization released the most comprehensive report to date on the alarming worldwide growth of antibiotic resistance, warning that we are already entering a world without antibiotics. The World Health Organization has sounded a loud… Continue Reading →
With risks growing that Ebola could flare on foreign shores, the U.S. is calling for nations to dispatch doctors and nurses to West Africa, where thousands of lives are on the line. Few have heeded the call, but one country… Continue Reading →
Ill-health is the price rural Indians have to pay for seeking a better life in the city. Twenty-nine villages near Hyderabad are helping to explain why, Michael Regnier discovers. Giles Newton, mosaic.com Photo Credit: Ben Gilbert/Wellcome Images A warm egg,… Continue Reading →
Risks for India’s Coherent, Pro-Public Health IP Policy Da admin Creata il 10/05/2014 – 16:01 …U.S. business interests and government officials are trying to sell the idea that heightened intellectual property protections in India are essential to foreign investment, innovation, and achievement… Continue Reading →
By KATIE THOMAS, AGUSTIN ARMENDARIZ and SARAH COHENSEPT. 30, 2014 Pharmaceutical and device makers paid doctors roughly $380 million in speaking and consulting fees, with some doctors reaping over half a million dollars each, during a five-month period last year, according to an analysis… Continue Reading →
Wednesday, 1 October 2014 – 7:00am IST | Place: New Delhi | Agency: DNA Iftikhar Gilani The Union government decision to decontrol prices of 108 drugs — used to treat tuberculosis, AIDS, diabetes and heart ailments — has jacked up… Continue Reading →
: Delhi High Court Tuesday, 30 September 2014 – 7:02pm IST | Place: New Delhi | Agency: PTI The Delhi High Court o Tuesday asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising… Continue Reading →
Rema Nagarajan, TNN | Sep 15, 2014, 02.43AM IST inShare 63 Unnecessary stent usage worries docs Most patients are forced to pay anything between Rs 60,000 and Rs 1 lakh or more for cardiac drug eluting stents (DES) though the… Continue Reading →
Syed Intishab Ali,TNN | Aug 18, 2014, 01.59 AM IST JAIPUR: With panchayat and municipal elections drawing nearer, the demand for removal of the two-child norm has intensified. Civil rights activists claim that the two-child norm has given rise to female feticide… Continue Reading →